Massive flu drug showdown: 3,000 volunteers needed to find best antiviral
NCT ID NCT05648448
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares different antiviral drugs to see which one clears the flu virus fastest. It involves 3,000 adults aged 18-60 with early flu symptoms. Participants are randomly assigned to receive a drug or no treatment, and their viral levels are tracked daily for a week.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Faculty of Tropical Medicine, Mahidol University
RECRUITINGBangkok, 10400, Thailand
-
Laos-Oxford-Mahosot Wellcome Trust Research unit
RECRUITINGVientiane, Laos
-
Sukraraj Tropical & Infectious Disease Hospital
RECRUITINGKathmandu, Nepal
-
Universidade Federal de Minas Gerais
RECRUITINGMinas Gerais, Brazil
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Flu vaccine showdown: which shot protects seniors best?
- Can a simple breath test catch flu in High-HIV regions?
- Can a simple mask stop the flu? 2,000 volunteers put it to the test
- Can a stronger flu shot better protect seniors?
- Can a lab-made flu vaccine outperform the traditional egg-based shot?
- Flu shot showdown: Cell-Grown vs recombinant vaccine put to the test